Radiation therapy in Peyronie's disease

Area of Science:

• Urology
• Radiation Oncology

Background:

• Peyronie's disease (PD) involves fibrotic plaque formation, causing penile deformity, pain, and erectile dysfunction.
• The etiology and pathophysiology of PD are not well understood, with no standardized reporting or management consensus.
• Current treatment options for PD lack definitive guidelines and universally accepted success criteria.

Purpose of the Study:

• To review the efficacy and safety of radiation therapy (RT) as a treatment for Peyronie's disease (PD).

Main Methods:

• Literature review and informed expert opinion were utilized.
• Evaluation focused on reported improvements in pain, curvature, plaque size, and erectile function.
• Safety profile of RT in PD patients was also assessed.

Main Results:

• RT has yielded variable results for PD treatment.
• Low-dose RT may offer benefits for early-stage PD with painful erections unresponsive to other therapies.
• Inconclusive results stem from a lack of standardized outcome measures, absence of randomized controlled trials, and potential negative effects of radiation on erectile tissue.

Conclusions:

• Mixed clinical success and safety concerns lead to a recommendation against using RT for Peyronie's disease management.
• The absence of validated assessment tools and potential harm to erectile function further support this recommendation.